You will also find in our portfolio
Offering
At the center of our portfolio stand medicines designed to treat type 2 diabetes and complications accompanying this disease. We also offer medicines for the treatment of opioid-induced constipation, breakthrough pain and the treatment and prophylaxis of thromboembolic disease.
A medicinal product for the treatment of adult patients with multiple myeloma and previously untreated mantle cell lymphoma in the form of powder for solution for injection.
naloxegol
Medicine from the group of peripherally acting µ-opioid receptor antagonists in the gastrointestinal tract, reducing the constipation effects of opioids without affecting their analgesic effect on the central nervous system, treatment of opioid-induced constipation, in the form of tablets.
repaglinide
Medicine from the glinides group, oral antidiabetic, treatment of type 2 diabetes mellitus, treatment of postprandial glycemia, in the form of tablets.